Clinical Trials · NCT06073184
Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- GynOncTrials
- Enrollment
- 71
- Start date
- Sep 2026
- Locations
- 1 site, Canada
- Primary endpoint
- Assessment of Complete Pathologic Response